Evidence map›Paper›PMID 27567407›Full record

GuidelineEuropean heart journal2016

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias.

Alberico L Catapano, Ian Graham, Guy De Backer, Olov Wiklund, M John Chapman, Heinz Drexel, Arno W Hoes, Catriona S Jennings, Ulf Landmesser, Terje R Pedersen and 10 more

5 registry-linked trialsAbstract readPractice Guideline
PubMed Publisher
In one paragraph

Guideline in European heart journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 5 registered trials, which are not on this map. Cited by 980 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
980citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03329729 completedstarted 2018, after this paper: background citation

Non-interventional, Multicenter Clinical Trial to Investigate the Efficacy of Rosuvastatin in Patients With Hyperlipidemia and Other Cardiovascular Risk Factors.

Ran2018Enrolled4,700Registered outcomes3Posted comparisons0ConditionsDyslipidemias, Hyperlipidemias, Quality of Life, Risk Factor, CardiovascularArmsRosuvastatin
Open the trial in the graph
NCT04338165 phase2unknown statusstarted 2021, after this paper: background citation

Effect of Impact of PCSK9 Inhibitors on Coronary Microvascular Dysfunction in Patients With Atherosclerotic Cardiovascular Disease Proved by Myocardial Ischemia and Needing Coronarography : a Monocentric, Prospective, Randomized and Open-label Phase II Trial

Ran2021Enrolled66Registered outcomes6Posted comparisons0ConditionsAtherosclerotic Cardiovascular DiseaseArmsEvolocumab 140 MG/ML [Repatha]
Open the trial in the graph
NCT06501287 unknown statusnot on this mapstarted 2024, after this paper: background citation

Postprandial Triglyceride Impact on Coronary Atherosclerosis in Non-Diabetic Patient in Sohag University Hospital [NCT ID Not Yet Assigned]

TypeobservationalSponsorFatma Madhy EissaRan2024 to 2024Enrolled160ConditionsCoronary AtherosclerosesArmsPostprandial triglyceride
NCT06526013 naunknown statusnot on this mapstarted 2024, after this paper: background citation

Cholesterol Self-testing in Patients Post Acute Coronary Syndrome

TypeinterventionalSponsorUniversity of LeipzigRan2024 to 2025Enrolled200ConditionsAcute Coronary Syndrome, Prevention, LDL Hyperlipoproteinemia, Therapeutic AdherenceArmsCholesterol self-measurement
NCT06929403 nacompletednot on this mapstarted 2024, after this paper: background citation

Effect of Dietary Supplement Containing Bergamot and Plant Sterols Extract on Serum Lipid Profile

TypeinterventionalSponsorIstanbul Bilgi UniversityRan2024 to 2025Enrolled61ConditionsDyslipidemia, Cardiac Disease, Cardiovascular DiseasesArmsDiet, Diet supplementation
3 · Its place in the literature

Who cites it

980 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Association between multiple sleep dimensions in obstructive sleep apnea and an early sign of atherosclerosis.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2024
    Trial
  9. Trial
  10. Trial
  11. Article
  12. Article
  13. Quantifying the inclusion of cardiovascular research into clinical guidelines.Clinical research in cardiology : official journal of the German Cardiac Society · 2026
    Article
  14. Article
  15. Article
  16. Observational
  17. Observational
  18. Article
  19. Biologics for cardiovascular diseases: from bench to bedside.Signal transduction and targeted therapy · 2026
    Review
  20. Article

920 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

Alberico L Catapano
Ian Graham
Guy De Backer
Olov Wiklund
M John Chapman
Heinz Drexel
Arno W Hoes
Catriona S Jennings
Ulf Landmesser
Terje R Pedersen
Željko Reiner
Gabriele Riccardi
Marja-Riita Taskinen
Lale Tokgozoglu
W M Monique Verschuren
Charalambos Vlachopoulos
David A Wood
Jose Luis Zamorano
Marie-Therese Cooney
ESC Scientific Document Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CardiologyCardiovascular DiseasesDyslipidemiasEuropeHumansRiskSex FactorsSocieties, Medicalapolipoprotein Bcholesteroldyslipidaemiashigh-density lipoproteinslipoprotein remnantslow-density lipoproteinstotal cardiovascular risktreatment, adherencetreatment, drugstreatment, lifestyletriglycerides

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.